1. Luca F, Goichot B, Brue T. Non thyroidal illnesses (NTIS). Ann Endocrinol (Paris) 2010; 71 (Suppl 1): S13–S24.
2. Gentile F, Conte M, Formisano S. Thyroglobulin as an autoantigen: what can we learn about immunopathogenicity from the correlation of antigenic properties with protein structure? Immunology 2004; 112 (1): 13–25.
3. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002; 87 (2): 489–499.
4. Zimmermann MB. Iodine deficiency. Endocr Rev 2009; 30 (4): 376–408.
5. Teng X, Shan Z, Chen Y, et al. More than adequate iodine intake may increase subclinical hypothyroidism and autoimmune thyroiditis: a cross-sectional study based on two Chinese communities with different iodine intake levels. Eur J Endocrinol 2011; 164 (6): 943–950.
6. Pedersen IB, Knudsen N, Carlé A, et al. A cautious iodization programme bringing iodine intake to a low recommended level is associated with an increase in the prevalence of thyroid autoantibodies in the population Clin Endocrinol (Oxf) 2011; 75 (1): 120–126.
7. Spencer CA, Takeuchi M, Kazarosyan M. Current status and performance goals for serum thyroglobulin assays. Clin Chem 1996; 42 (1): 164–173.
8. Venkatesh SG, Deshpande V. A comparative review of the structure and biosynthesis of thyroglobulin. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 1999; 122 (1): 13–20.
9. Park YN, Arvan P. The acetylcholinesterase homology region is essential for normal conformational maturation and secretion of thyroglobulin. J Biol Chem 2004; 279 (17): 17085–17089.
10. WHO, UNICEF, ICC IDD. Assessment of Iodine Deficiency Disorders and Monitoring Their Elimination: A Guide for Programme Managers. 3rd ed. Geneva: WHO; 2007.
11. Zimmermann MB, de Benoist B, Corigliano S, et al. Assessment of iodine status using dried blood spot thyroglobulin: development of reference material and establishment of an international reference range in iodine-sufficient children. J Clin Endocrinol Metab 2006; 91: 4881–4887.
12. Zimmermann MB, Aeberli I, Andersson M, et al. Thyroglobulin is a sensitive measure of both deficient and excess iodine intakes in children and indicates no adverse effects on thyroid function in the UIC range of 100-299 μg/L: a UNICEF/ICCIDD study group report. J Clin Endocrinol Metab 2013; 98 (3): 1271–1280.
13. Bílek R, Čeřovská J, Zamrazil V. The relationship between iodine intake and serum thyroglobulin in the general population. Physiol Res 2015; 64 (3): 345–353.
14. Giovanella L, Ceriani L. Comparison of thyroglobulin antibody interference in first- and second-generation thyroglobulin immunoassays. Clin Chem Lab Med 2011; 49 (6): 1025–1027.
15. Spencer CA, Bergoglio LM, Kazarosyan M, et al. Clinical impact of thyroglobulin (Tg) and Tg autoantibody method differences on the management of patients with differentiated thyroid carcinomas. J Clin Endocrinol Metab 2005; 90 (10): 5566–5575.
16. Clark P, Franklyn J. Can we interpret serum thyroglobulin results? Ann Clin Biochem 2012; 49 (Pt 4): 313–322.
17. Preissner CM, O‘Kane DJ, Singh RJ, et al. Phantoms in the assay tube: heterophile antibody interferences in serum thyroglobulin assays. J Clin Endocrinol Metab 2003; 88 (7): 3069–3074.
18. Giovanella L, Keller F, Ceriani L, Tozzoli R. Heterophile antibodies may falsely increase or decrease thyroglobulin measurement in patients with differentiated thyroid carcinoma. Clin Chem Lab Med 2009; 47: 952–954.
19. Feldt-Rasmussen U, Profilis C, Colinet E, et al. Human thyroglobulin reference material (CRM 457): 1st Part: Assessment of homogeneity, stability and immunoreactivity. Ann Biol Clin (Paris) 1996; 54 (10–11): 337–342.
20. Feldt-Rasmussen U, Profilis C, Colinet E, et al. Human thyroglobulin reference material (CRM 457): 2nd Part: Physicochemical characterization and certification. Ann Biol Clin (Paris) 1996; 54 (10–11): 343–348.
21. Bílek R, Zamrazil V. Thyroglobulin as an indicator of iodine intake. In: Preedy VR, Burrow GN, Watson R (eds). Comprehensive Handbook on Iodine: Nutritional, Biochemical, Pathological and Therapeutic Aspects. Oxford: Academic Press, 2009: 55–64.
22. Hoofnagle AN, Roth MY. Clinical review: improving the measurement of serum thyroglobulin with mass spectrometry. J Clin Endocrinol Metab 2013; 98 (4): 1343–1352.
23. Kushnir MM, Rockwood AL, Roberts WL, et al. Measurement of thyroglobulin by liquid chromatography-tandem mass spectrometry in serum and plasma in the presence of antithyroglobulin autoantibodies. Clin Chem 2013; 59 (6): 982–990.
24. Bilek R, Bednar J, Zamrazil V. Spectrophotometric determination of urinary iodine by the Sandell-Kolthoff reaction subsequent to dry alkaline ashing: Results from the Czech Republic in the period 1994–2002. Clin Chem Lab Med 2005; 43 (6): 573–850.
25. Hníková O, Delange F, Kračmar P, et al. Experience in the monitoring of maternal and neonatal iodine supply in the Czech Republic. Ces-slov Pediat 2005; 60 (1): 3–6.
26. Ristic-Medic D, Piskackova Z, Hooper L, et al. Methods of assessment of iodine status in humans: a systematic review. Am J Clin Nutr 2009; 89 (6): 2052S–2069S.